# US 2026/0053146 A1 · Mastoparan peptides as treatment against liberibacter-caused crop diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0053146 A1
- Document ID: US20260053146A1
- Status: Published application
- Kind: A1
- Application number: 19/235,666
- Filed: 2025-06-12
- Published: 2026-02-26
- Earliest claimed: 2024-06-21
- Applicants: The United States of America, as represented by the Secretary of Agriculture
- Inventors: MICHELLE L HECK; LUKE A THOMPSON; SAMUEL CORADETTI
- Web page: https://patentgrep.com/patent/US20260053146A1

## CPC

- A01N 63/50: Isolated enzymes; Isolated proteins (peptides A01N37/46)
- A01N 63/14: Insects
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- C07K 14/435: from animals; from humans
- C07K 14/43563: {from insects}
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The disclosure relates to bioactive compositions comprising at least one mastoparan peptide and a carrier and/or adjuvant, or at least one modified mastoparan peptide and use of such bioactive compositions to protect plants from infection by pests or pathogens. More specifically, the disclosure provides a method for treating and/or ameliorating a pest and/or pathogen in a Citrus or Solanaceae plant or plant part in need thereof, the method comprising treating the plant or plant part with an effective amount of a bioactive composition comprising at least one mastoparan peptide and a carrier and/or adjuvant, or at least one modified mastoparan peptide to treat and/or ameliorate the pest and/or pathogen in the Citrus or Solanaceae plant.

## Claims

### Claim 1

A bioactive composition comprising at least one modified mastoparan peptide.

### Claim 2 (depends on 1)

The bioactive composition of claim 1, wherein the at least one modified mastoparan peptide is modified by an N-terminal modification, an N-terminal substitution, a C-terminal modification, a C-terminal substitution, a presence of a D-amino acid, a presence of an unnatural amino acid, cyclization, or a mixture thereof.

### Claim 3 (depends on 2)

The bioactive composition of claim 2, wherein the at least one mastoparan peptide is modified by an N-terminal modification, wherein the N-terminal modification is acetylation, methylation, myristylation, or palmitoylation.

### Claim 4 (depends on 2)

The bioactive composition of claim 2, wherein the at least one mastoparan peptide is modified by a C-terminal modification, wherein the C-terminal modification is addition of an acid, an amide, an ester, an aldehyde, a para-nitroanilide, 7-amino-4-methylcoumarin, hydrazide, hydroxamic acid, or chloromethyl ketone.

### Claim 5 (depends on 1)

The bioactive composition of claim 1, wherein the at least one modified mastoparan peptide has the amino acid sequence as set forth in any one of SEQ ID NO: 1 to SEQ ID NO: 41, or a mixture thereof.

### Claim 6 (depends on 5)

The bioactive composition of claim 5, wherein the at least one modified mastoparan peptide has the amino acid sequence as set forth in SEQ ID NO: 14; SEQ ID NO: 9; SEQ ID NO: 4; SEQ ID NO: 34; SEQ ID NO:31; SEQ ID NO: 18; or a mixture thereof.

### Claim 7 (depends on 1)

The bioactive composition of claim 1, wherein the at least one modified mastoparan peptide is expressed in a host cell.

### Claim 8 (depends on 7)

The bioactive composition of claim 7, wherein the host cell is a plant cell.

### Claim 9 (depends on 1)

A method for treating and/or ameliorating a pest and/or pathogen in a subject in need thereof, the method comprising treating the subject with an effective amount of the bioactive composition of claim 1 to treat or ameliorate the pest and/or pathogen in the subject.

### Claim 10 (depends on 9)

The method of claim 9, wherein the modified mastoparan peptide in the bioactive composition is modified by an N-terminal modification, an N-terminal substitution, a C-terminal modification, a C-terminal substitution, a presence of a D-amino acid, a presence of an unnatural amino acid, cyclization, or a mixture thereof.

### Claim 11 (depends on 10)

The method of claim 10, wherein the mastoparan peptide in the bioactive composition is modified by an N-terminal modification, wherein the N-terminal modification is acetylation, methylation, myristylation, or palmitoylation.

### Claim 12 (depends on 10)

The method of claim 10, wherein the mastoparan peptide in the bioactive composition is modified by a C-terminal modification, wherein the C-terminal modification is addition of an acid, an amide, an ester, an aldehyde, a para-nitroanilide, 7-amino-4-methylcoumarin, hydrazide, hydroxamic acid, or chloromethyl ketone.

### Claim 13 (depends on 9)

The method of claim 9, wherein the at least one modified mastoparan peptide has the amino acid sequence as set forth in any one of SEQ ID NO: 1 to SEQ ID NO: 41, or a mixture thereof.

### Claim 14 (depends on 13)

The method of claim 13, wherein the at least one mastoparan peptide has the amino acid sequence as set forth in SEQ ID NO: 14; SEQ ID NO: 9; SEQ ID NO: 4; SEQ ID NO: 34; SEQ ID NO:31; SEQ ID NO: 18; or a mixture thereof.

### Claim 15 (depends on 9)

The method of claim 9, wherein the subject is a plant.

### Claim 16 (depends on 15)

The method of claim 15, wherein the plant is infected with a Liberibacter-species.

### Claim 17 (depends on 16)

The method of claim 16, wherein the plant infected with a Liberibacter-species is citrus plant or a Solanaceae plant.

### Claim 18

A plant biopesticide composition comprising at least one mastoparan peptide and an adjuvant or carrier.

### Claim 19 (depends on 18)

The plant biopesticide composition of claim 18, wherein the at least one mastoparan peptide has the amino acid sequence as set forth in any one of SEQ ID NO: 1 to SEQ ID NO: 41, or a mixture thereof.
